Page last updated: 2024-08-16

pipobroman and hydroxyurea

pipobroman has been researched along with hydroxyurea in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (5.13)	18.7374
1990's	15 (38.46)	18.2507
2000's	14 (35.90)	29.6817
2010's	7 (17.95)	24.3611
2020's	1 (2.56)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Najean, Y	1
Dresch, C; Najean, Y; Rain, JD	1
Greenwald, ES	1
Fuse, I	1
Boivin, P	1
Dresch, C; Echard, M; Goguel, A; Grange, MJ; Lejeune, F; Najean, Y; Rain, JD	1
Barbui, T; Brière, J; Dupuy, E; Finazzi, G; Kiladjian, JJ	1
Najean, Y; Rain, JD	1
Nevado Reviriego, I; Román Barbero, A; Sánchez Fayos, J	1
Tefferi, A	1
Green, AR; Harrisoni, G; Pearson, TC; Reilly, JT	1
Gisslinger, B; Gisslinger, H; Heis, N; Knöbl, P; Lechner, K; Rintelen, C	1
Bauters, F	1
Fabris, F; Girolami, A; Randi, ML	2
Silverstein, MN; Tefferi, A	1
Hehlmann, R; Lengfelder, E	1
Rain, JD	2
Briere, J; Guilmin, F	1
Bangerter, M; Griesshammer, M; Grünewald, M	1
Brahimi, S; Echard, M; Fermand, JP; Gruyer, P; Lejeune, F; Najean, Y; Rain, JD	1
Bernasconi, C; Bernasconi, P; Boni, M; Brusamolino, E; Calatroni, S; Caresana, M; Cavigliano, PM; Giardini, I; Lazzarino, M; Passamonti, F; Pistorio, A; Rocca, B; Volpe, G	1
Bertola, G; Lodato, A; Sciariada, L; Sironi, M; Spinelli, M	1
Griesshammer, M; Langer, C	1
Cazzola, M; Passamonti, F	1
Bernard, JF; Briere, J; Chomienne, C; Fenaux, P; Kiladjian, JJ; Rain, JD	1
McMullin, MF	1
Reilly, JT	1
Chevret, S; Chomienne, C; Dosquet, C; Kiladjian, JJ; Rain, JD	1
Newberry, KJ; Sever, M; Verstovsek, S	1
Moliterno, AR; Stein, BL; Tiu, RV	1
Barbui, T; Tefferi, A	1
Abruzzese, E; Bondanini, F; de Fabritiis, P; Fratoni, S; Giovannini, M; Neri, B; Niscola, P; Palumbo, R; Scaramucci, L; Siniscalchi, A; Tendas, A; Trawinska, MM	1
Anaclerico, B; Andriani, A; Aroldi, A; Breccia, M; Carmosino, I; Centra, A; Di Veroli, A; Elli, E; Fianchi, L; Foà, R; Latagliata, R; Martini, V; Montanaro, G; Montanaro, M; Niscola, P; Trapè, G; Villivà, N; Voso, MT	1
Alvarez-Larran, A; Angona, A; Barbui, T; Beggiato, E; Benevolo, G; Bertolotti, L; Betti, S; Bonifacio, M; Cacciola, R; Carli, G; Carobbio, A; Casetti, IC; Cattaneo, D; De Stefano, V; Delaini, F; Di Veroli, A; Elli, EM; Erez, D; Finazzi, G; Fox, ML; Ghirardi, A; Gomez, M; Griesshammer, M; Guglielmelli, P; Iurlo, A; Lunghi, F; Marchetti, M; Masciulli, A; McMullin, MF; Palandri, F; Palova, M; Patriarca, A; Perez-Encinas, M; Recasens, V; Rumi, E; Scaffidi, L; Stephenson, C; Tieghi, A; Vannucchi, AM; Vianelli, N; Wille, K	1
Besses, C; Blau, IW; Dong, T; Durrant, S; Francillard, N; Griesshammer, M; Harrison, CN; Hino, M; Kiladjian, JJ; Kirito, K; Masszi, T; Mesa, R; Miller, CB; Moiraghi, B; Pane, F; Passamonti, F; Rosti, V; Rumi, E; Vannucchi, AM; Verstovsek, S; Wroclawska, M; Zachee, P	1

Reviews

15 review(s) available for pipobroman and hydroxyurea

Article	Year
Cancer chemotherapy. II. New York state journal of medicine, 1972, Nov-01, Volume: 72, Issue:21 Topics: Animals; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Cytarabine; Dactinomycin; Daunorubicin; Dimethylamines; Doxorubicin; Floxuridine; Fluorouracil; Humans; Hydroxyurea; Imidazoles; Mercaptopurine; Mitomycins; Mitotane; Neoplasms; Nitrosourea Compounds; Pipobroman; Procarbazine; Streptonigrin; Streptozocin; Thioguanine; Triazenes; Triazines; Vinblastine; Vincristine	1972
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias". Leukemia & lymphoma, 1996, Volume: 22 Suppl 1 Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid; Leukemia, Radiation-Induced; Lymphoma; Neoplasms, Radiation-Induced; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Prevalence; Primary Myelofibrosis; Risk; Splenomegaly	1996
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers. Leukemia & lymphoma, 1996, Volume: 22 Suppl 1 Topics: Adult; Aged; Alkylating Agents; Anemia, Megaloblastic; Arrhythmias, Cardiac; Bone Marrow Diseases; Busulfan; Female; Hemorrhage; Humans; Hydroxyurea; Immunologic Factors; Incidence; Interferon-alpha; Ischemic Attack, Transient; Leukemia; Male; Middle Aged; Pipobroman; Platelet Aggregation Inhibitors; Platelet Count; Prognosis; Quinazolines; Risk Factors; Thrombocythemia, Essential; Thrombosis	1996
[Efficacious treatment of a fatal blood disease: polycythemia vera]. Sangre, 1997, Volume: 42, Issue:3 Topics: Acute Disease; Alkylating Agents; Busulfan; Chlorambucil; Humans; Hydroxyurea; Leukemia, Myeloid; Leukemia, Radiation-Induced; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Platelet Aggregation Inhibitors; Polycythemia Vera; Randomized Controlled Trials as Topic; Survival Rate	1997
[Vaquez disease. Diagnosis, course, treatment]. La Revue du praticien, 1998, Sep-01, Volume: 48, Issue:13 Topics: Aged; Antineoplastic Agents, Alkylating; Antisickling Agents; Diagnosis, Differential; Female; Humans; Hydroxyurea; Injections, Intravenous; Interferon-alpha; Male; Middle Aged; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Risk Factors; Sex Factors	1998
Treatment of polycythaemia vera and essential thrombocythaemia. Bailliere's clinical haematology, 1998, Volume: 11, Issue:4 Topics: Adult; Aged; Aspirin; Chlorambucil; Disease Progression; Female; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Prospective Studies; Quinazolines; Thrombocythemia, Essential; Thrombosis	1998
[Polycythemia vera: current status of therapy]. Deutsche medizinische Wochenschrift (1946), 2000, Oct-13, Volume: 125, Issue:41 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bloodletting; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Hydroxyurea; Interferon-alpha; Leukemia; Middle Aged; Phlebotomy; Pipobroman; Platelet Aggregation Inhibitors; Polycythemia Vera; Prognosis; Prospective Studies; Quinazolines; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Thromboembolism	2000
Management of patients with essential thrombocythemia: current concepts and perspectives. Pathologie-biologie, 2001, Volume: 49, Issue:2 Topics: Adult; Aged; Aspirin; Case Management; Clinical Trials as Topic; Diagnosis, Differential; Disease Progression; Female; Hemorrhagic Disorders; Humans; Hydroxyurea; Interferons; Leukemia; Male; Middle Aged; Pipobroman; Platelet Aggregation Inhibitors; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Quinazolines; Risk; Safety; Thrombocythemia, Essential; Thrombophilia	2001
Current treatment practice for essential thrombocythaemia in adults. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:3 Topics: Adult; Aspirin; Humans; Hydroxyurea; Interferon-alpha; Pipobroman; Prognosis; Quinazolines; Thrombocythemia, Essential	2001
[Polycythemia vera]. La Revue du praticien, 2002, Oct-15, Volume: 52, Issue:16 Topics: Aged; Diagnosis, Differential; Erythrocyte Count; Female; Hematocrit; Humans; Hydroxyurea; Male; Middle Aged; Neoadjuvant Therapy; Pipobroman; Polycythemia Vera; Quality of Life; Splenomegaly	2002
Pharmacotherapy of essential thrombocythaemia: economic considerations. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:9 Topics: Age Factors; Antineoplastic Agents; Aspirin; Clinical Trials, Phase II as Topic; Cost-Benefit Analysis; Humans; Hydroxyurea; Interferon-alpha; Pipobroman; Quinazolines; Risk Factors; Thrombocythemia, Essential	2003
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia. Seminars in thrombosis and hemostasis, 2006, Volume: 32, Issue:4 Pt 2 Topics: Antineoplastic Agents, Alkylating; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Leukemia; Male; Mutation; Myelodysplastic Syndromes; Pipobroman; Polycythemia Vera; Prospective Studies; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Randomized Controlled Trials as Topic; Retrospective Studies; Thrombocythemia, Essential; Time Factors	2006
A review of the therapeutic agents used in the management of polycythaemia vera. Hematological oncology, 2007, Volume: 25, Issue:2 Topics: Hematocrit; Humans; Hydroxyurea; Interferons; Pipobroman; Polycythemia Vera; Randomized Controlled Trials as Topic	2007
Therapeutic options for patients with polycythemia vera and essential thrombocythemia refractory/resistant to hydroxyurea. Leukemia & lymphoma, 2014, Volume: 55, Issue:12 Topics: Antineoplastic Agents; Busulfan; Disease Management; Drug Resistance; Histone Deacetylase Inhibitors; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Pipobroman; Platelet Aggregation Inhibitors; Polycythemia Vera; Protein Kinase Inhibitors; Quinazolines; Thrombocythemia, Essential; Treatment Outcome	2014
Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options. Annals of hematology, 2014, Volume: 93, Issue:12 Topics: Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cost of Illness; Disease Progression; Fatigue; Health Care Costs; Hemorrhagic Disorders; Humans; Hydroxyurea; Interferons; Janus Kinase 2; Leukemia, Myeloid, Acute; Mutation, Missense; Neoplasms, Second Primary; Nitriles; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quality of Life; Therapies, Investigational; Thrombophilia	2014

Trials

8 trial(s) available for pipobroman and hydroxyurea

Article	Year
[Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies]. Presse medicale (Paris, France : 1983), 1992, Nov-07, Volume: 21, Issue:37 Topics: Digestive System Diseases; Female; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Pipobroman; Polycythemia Vera; Skin Diseases; Stomatitis, Aphthous	1992
Intermediary analysis of a French protocol of treatment of polycythemias (1980-1990): 253 patients. The French Group for the Study of Polycythemias. Nouvelle revue francaise d'hematologie, 1991, Volume: 33, Issue:2 Topics: Clinical Protocols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxyurea; Male; Piperazines; Pipobroman; Polycythemia Vera	1991
Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea. Nouvelle revue francaise d'hematologie, 1993, Volume: 35, Issue:5 Topics: Acute Disease; Bloodletting; Combined Modality Therapy; Humans; Hydroxyurea; Leukemia; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Splenomegaly; Vascular Diseases	1993
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias". Leukemia & lymphoma, 1996, Volume: 22 Suppl 1 Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid; Leukemia, Radiation-Induced; Lymphoma; Neoplasms, Radiation-Induced; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Prevalence; Primary Myelofibrosis; Risk; Splenomegaly	1996
Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood, 1997, Nov-01, Volume: 90, Issue:9 Topics: Antineoplastic Agents; Female; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Pipobroman; Polycythemia Vera; Remission Induction; Treatment Outcome	1997
[Treatment of polycythemia. II.--Comparison of hydroxyurea with pipobroman in 294 patients less than 65 years of age]. Annales de medecine interne, 1998, Volume: 149, Issue:2 Topics: Adult; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Pipobroman; Polycythemia Vera; Prospective Studies; Risk Factors; Survival Rate	1998
Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Oct-10, Volume: 29, Issue:29 Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Pipobroman; Polycythemia Vera; Survival Analysis; Young Adult	2011
Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study. The Lancet. Haematology, 2020, Volume: 7, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Nitriles; Pipobroman; Polycythemia Vera; Polyethylene Glycols; Prognosis; Pyrazoles; Pyrimidines; Quinazolines; Recombinant Proteins; Survival Rate; Time Factors	2020

Other Studies

17 other study(ies) available for pipobroman and hydroxyurea

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Drugs in the treatment of leukemia. British medical journal, 1968, Nov-02, Volume: 4, Issue:5626 Topics: Asparaginase; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Pipobroman; Prednisolone; Vincristine	1968
[Recent trends in therapy of chronic myeloproliferative disorders]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Jul-10, Volume: 82, Issue:7 Topics: Alkylating Agents; Aspirin; Humans; Hydroxyurea; Interferons; Pipobroman; Prognosis; Thrombocythemia, Essential	1993
Is hydroxyurea leukemogenic in essential thrombocythemia? Blood, 1998, Aug-15, Volume: 92, Issue:4 Topics: Acute Disease; Antineoplastic Agents, Alkylating; Bone Marrow; Busulfan; Chromosome Aberrations; Chromosomes, Human, Pair 17; Diagnosis, Differential; Disease Progression; Humans; Hydroxyurea; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Myelodysplastic Syndromes; Pipobroman; Polycythemia Vera; Research Design; Retrospective Studies; Risk; Thrombocythemia, Essential	1998
Leukemic transformation in polycythemia Vera. MPD(UK) Study Group. Blood, 1998, Sep-01, Volume: 92, Issue:5 Topics: Antineoplastic Agents; Humans; Hydroxyurea; Leukemia; Pipobroman; Polycythemia Vera	1998
The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera. European journal of haematology, 1999, Volume: 62, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Busulfan; Drug Tolerance; Erysipelas; Erythropoiesis; Female; Hematocrit; Humans; Hydroxyurea; Interferon-alpha; Leukopoiesis; Male; Middle Aged; Phlebotomy; Pipobroman; Polycythemia Vera; Syncope; Thrombosis; Time Factors; Treatment Outcome	1999
Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents. Haematologica, 1999, Volume: 84, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Busulfan; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Phosphorus Radioisotopes; Pipobroman; Retrospective Studies; Thrombocythemia, Essential	1999
Leukemia and myelodysplasia effect of multiple cytotoxic therapy in essential thrombocythemia. Leukemia & lymphoma, 2000, Volume: 37, Issue:3-4 Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Busulfan; Fatal Outcome; Female; Humans; Hydroxyurea; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Phosphorus Radioisotopes; Pipobroman; Thrombocythemia, Essential	2000
[Hydroxyurea--is it a harmless drug in Vaquez disease?]]. Pathologie-biologie, 2001, Volume: 49, Issue:2 Topics: Aged; Alopecia; Combined Modality Therapy; Cystitis; Erectile Dysfunction; Female; Fever; Follow-Up Studies; Humans; Hydroxyurea; Incidence; Leg Ulcer; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neural Tube Defects; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Prospective Studies; Risk; Safety; Stomatitis, Aphthous	2001
Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia, 2002, Volume: 16, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chromosome Aberrations; Female; Humans; Hydroxyurea; In Situ Hybridization, Fluorescence; Leukemia, Myeloid; Male; Middle Aged; Pipobroman; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Thrombocythemia, Essential	2002
Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea. Acta haematologica, 2003, Volume: 109, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Humans; Hydroxyurea; Leukemia, Megakaryoblastic, Acute; Male; Megakaryocytes; Middle Aged; Pipobroman; Thrombocythemia, Essential; Time Factors	2003
Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug. Haematologica, 2004, Volume: 89, Issue:11 Topics: Adult; Humans; Hydroxyurea; Middle Aged; Pipobroman; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Thrombocythemia, Essential; Thromboembolism	2004
Practical approach to treating essential thrombocythaemia: case studies. European journal of haematology. Supplementum, 2007, Issue:68 Topics: Adult; Aspirin; Disease Management; Female; Humans; Hydroxyurea; Interferon-alpha; Leg Ulcer; Male; Middle Aged; Pipobroman; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Quinazolines; Thrombocythemia, Essential; Warfarin	2007
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. American journal of hematology, 2019, Volume: 94, Issue:1 Topics: Adult; Aspirin; Bone Marrow; Busulfan; Disease Management; Disease Progression; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Mutation; Phlebotomy; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Thrombocythemia, Essential; Thrombosis; Young Adult	2019
Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm. Acta haematologica, 2018, Volume: 140, Issue:4 Topics: Aged; Decitabine; Female; Humans; Hydroxyurea; Janus Kinase 2; Leukemia, Myeloid, Acute; Male; Myeloproliferative Disorders; Pipobroman; Treatment Outcome	2018
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors. Hematological oncology, 2019, Volume: 37, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Blast Crisis; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Melphalan; Middle Aged; Mutation; Myeloproliferative Disorders; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Remission Induction; Retrospective Studies; Thrombocythemia, Essential; Treatment Outcome	2019
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. Leukemia, 2019, Volume: 33, Issue:8 Topics: Antineoplastic Agents; Case-Control Studies; Humans; Hydroxyurea; Neoplasms, Second Primary; Nitriles; Philadelphia Chromosome; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Thrombocythemia, Essential	2019